Your healthcare provider will review your health history, current weight, body mass index (BMI), existing medical conditions, previous weight-loss efforts, and treatment goals to determine whether a GLP-1 medication is an appropriate option
Stay informed, stay prepared, and stay connected with newtropin.com for comprehensive coverage before, during, and after the PCAC review
Metas ad library listed 49 active ad campaigns by Novo Nordisk for Wegovy as of Tuesday
doi: 10.1021/jf0731200
Activity Restrictions While light activities like short walks are encouraged, avoid strenuous activities for at least the first few weeks
If your provider prescribes both medications but does not establish a monitoring plan (blood pressure checks, labs, scheduled follow-ups), that is a serious red flag about the quality of care